18 results on '"Brekke, Jorunn"'
Search Results
2. Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow‐up
3. En kvinne i 30-årenemed forvirring.
4. Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival
5. BORTEM-17: A phase IB/II single arm, multicentre study investigating the efficacy of sequential bortezomib and temozolomide in recurrent GBM with unmethylated MGMT promoter—The results of an interim analysis.
6. Investigating survival, quality of life and cognition in PROton versus photon therapy forIDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
7. Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions
8. Arterial Thromboembolism in Cancer Patients Treated with Apixaban
9. Abstract CT114: BORTEM-17 - phase IB/II single arm, non-randomized controlled multicenter study investigating whether sequential bortezomib and temozolomide is safe and effective in recurrent GBM with unmethylated MGMT promoter
10. Bortezomib sensitization of recurrent glioblastoma with unmethylated MGMT promoter to temozolomide, a phase II study (NCT03643549).
11. Low Dose Apixaban As Secondary Prophylaxis for Venous Thromboembolism in Cancer Patients, 30 Months Follow-up
12. Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
13. Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study
14. Tumor stromal desmoplasia and inflammatory response uniquely predict survival with and without stratification for HPV tumor infection in OPSCC patients
15. Abstract 2928: Bortezomib sensitizes glioblastoma with unmethylatedMGMTpromoter to temozolomide-chemotherapy through MGMT depletion and abrogated autophagy flux
16. Barnet er den Andre - Om pedagogens ansvar for barnet i lys av Levinas' etikk
17. A woman in her thirties with confusion.
18. Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH- mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.